Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1014 record(s)

Req # A-2021-000663

Adverse Drug Reaction (ADR) for HYOSCINE BUTYLBROMIDE. Report number: E2B_03293753.

Organization: Health Canada

14 page(s)
September 2023

Req # A-2022-001661

Adverse Drug Reaction (ADR). Report number: E2B_05716216.

Organization: Health Canada

11 page(s)
September 2023

Req # A-2023-000352

Adverse Drug Reaction (ADR) for LANREOTIDE. Report number: E2B_05322380.

Organization: Health Canada

23 page(s)
September 2023

Req # A-2023-000381

Adverse Drug Reactions (ADRs) for ZOSTAVAX II. Report numbers: E2B_03009425, E2B_01335934, E2B_02096585, E2B_01892634, E2B_02393844, E2B_02387551, E2B_02826826, E2B_02867073, E2B_02455143, E2B_03044908.

Organization: Health Canada

258 page(s)
September 2023

Req # A-2023-000416

Adverse Drug Reaction (ADR). Report number: 000630138.

Organization: Health Canada

3 page(s)
September 2023

Req # A-2023-000468

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-103496-815, Investing in Canada Plan.

Organization: Health Canada

20 page(s)
September 2023

Req # A-2023-000529

Adverse Drug Reaction (ADR). Report number: E2B_02891245.

Organization: Health Canada

28 page(s)
September 2023

Req # A-2023-000548

Adverse Drug Reaction (ADR). Report number: E2B_06076856.

Organization: Health Canada

69 page(s)
September 2023

Req # EA2023-0034408

Copy of briefing note # BN-2023-010 and attached letter to the Minister of National Defence recommending legislative reforms to enhance civilian oversight of the military police.

Organization: Military Police Complaints Commission of Canada

20 page(s)
September 2023

Req # A-2023-16

List of scientists who have worked in the Metrology Radiation Group at NRC since its inception.

Organization: National Research Council Canada

2 page(s)
September 2023
Date modified: